The link you have chosen leads to a site maintained by a third party over whom Bracco has no control.

As such, Bracco makes no representation as to the accuracy or any other aspect of the information on this site.

Do you want to continue?

OK

Cancel

Gadopiclenol: another milestone achieved

Priority Review of the Gadopiclenol NDA granted by the U.S. Food and Drug Administration”

Via Caduti di Marcinelle 13,
20134 Milan, Italy
phone + 39 02 2177.1